

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.85880129 |
| 2 | kynurenine metabolic process (GO:0070189) | 4.45652513 |
| 3 | regulation of hippo signaling (GO:0035330) | 4.36179765 |
| 4 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.29393898 |
| 5 | cellular response to ethanol (GO:0071361) | 4.20915799 |
| 6 | phospholipid translocation (GO:0045332) | 4.13743379 |
| 7 | lipid translocation (GO:0034204) | 4.13743379 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.13319525 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 4.13319525 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 4.13319525 |
| 11 | mitochondrial calcium ion transport (GO:0006851) | 3.81910178 |
| 12 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.80545536 |
| 13 | magnesium ion transport (GO:0015693) | 3.75182089 |
| 14 | tryptophan metabolic process (GO:0006568) | 3.62003858 |
| 15 | protein K11-linked deubiquitination (GO:0035871) | 3.61501319 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.49115195 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.45903362 |
| 18 | replicative senescence (GO:0090399) | 3.42600936 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37870577 |
| 20 | L-fucose catabolic process (GO:0042355) | 3.28338814 |
| 21 | fucose catabolic process (GO:0019317) | 3.28338814 |
| 22 | L-fucose metabolic process (GO:0042354) | 3.28338814 |
| 23 | interkinetic nuclear migration (GO:0022027) | 3.24758403 |
| 24 | insulin secretion (GO:0030073) | 3.24274690 |
| 25 | cellular response to exogenous dsRNA (GO:0071360) | 3.23708166 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18573248 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.18169233 |
| 28 | indolalkylamine metabolic process (GO:0006586) | 3.12309778 |
| 29 | behavioral response to nicotine (GO:0035095) | 3.12054562 |
| 30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.11405279 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09809236 |
| 32 | detection of calcium ion (GO:0005513) | 3.06806854 |
| 33 | sphingoid metabolic process (GO:0046519) | 3.06425436 |
| 34 | locomotory exploration behavior (GO:0035641) | 3.06412759 |
| 35 | regulation of ARF protein signal transduction (GO:0032012) | 3.05381130 |
| 36 | import into cell (GO:0098657) | 3.03688117 |
| 37 | response to pheromone (GO:0019236) | 3.02817416 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00492928 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00213940 |
| 40 | startle response (GO:0001964) | 2.95687475 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.94927632 |
| 42 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.91843129 |
| 43 | regulation of alkaline phosphatase activity (GO:0010692) | 2.91779302 |
| 44 | vitamin transmembrane transport (GO:0035461) | 2.91202203 |
| 45 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.90464393 |
| 46 | Golgi transport vesicle coating (GO:0048200) | 2.90209898 |
| 47 | COPI coating of Golgi vesicle (GO:0048205) | 2.90209898 |
| 48 | iron ion import (GO:0097286) | 2.89405452 |
| 49 | negative regulation of mast cell activation (GO:0033004) | 2.88635270 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 2.85748905 |
| 51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.85422626 |
| 52 | regulation of protein polyubiquitination (GO:1902914) | 2.84772578 |
| 53 | snRNA transcription (GO:0009301) | 2.78425556 |
| 54 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.77396745 |
| 55 | indole-containing compound metabolic process (GO:0042430) | 2.73852503 |
| 56 | positive regulation of developmental pigmentation (GO:0048087) | 2.71049472 |
| 57 | histone H3-K36 demethylation (GO:0070544) | 2.69930000 |
| 58 | endosome to melanosome transport (GO:0035646) | 2.69272411 |
| 59 | endosome to pigment granule transport (GO:0043485) | 2.69272411 |
| 60 | regulation of establishment of cell polarity (GO:2000114) | 2.68087712 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62016477 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 2.62016477 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62016477 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62016477 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62016477 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 2.62016477 |
| 67 | Golgi to endosome transport (GO:0006895) | 2.61683861 |
| 68 | opioid receptor signaling pathway (GO:0038003) | 2.61442283 |
| 69 | vocalization behavior (GO:0071625) | 2.61328692 |
| 70 | mitotic cell cycle arrest (GO:0071850) | 2.60759878 |
| 71 | serotonin metabolic process (GO:0042428) | 2.60320807 |
| 72 | sphingosine metabolic process (GO:0006670) | 2.59097190 |
| 73 | neuron cell-cell adhesion (GO:0007158) | 2.57855616 |
| 74 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.56802689 |
| 75 | neural tube formation (GO:0001841) | 2.56654296 |
| 76 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.56512186 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 2.56153092 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 2.54807652 |
| 79 | synaptic vesicle exocytosis (GO:0016079) | 2.54672375 |
| 80 | presynaptic membrane assembly (GO:0097105) | 2.53515044 |
| 81 | diol metabolic process (GO:0034311) | 2.52327630 |
| 82 | histone H3-K4 trimethylation (GO:0080182) | 2.51573311 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.51289376 |
| 84 | histone H3-K9 methylation (GO:0051567) | 2.50819961 |
| 85 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.50057938 |
| 86 | organ growth (GO:0035265) | 2.49937967 |
| 87 | peptidyl-lysine methylation (GO:0018022) | 2.49848416 |
| 88 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.49108659 |
| 89 | protein import into peroxisome matrix (GO:0016558) | 2.48649294 |
| 90 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.47748011 |
| 91 | response to auditory stimulus (GO:0010996) | 2.47271128 |
| 92 | multicellular organism reproduction (GO:0032504) | 2.46597394 |
| 93 | macroautophagy (GO:0016236) | 2.45971928 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.45966312 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.45316553 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 2.44368773 |
| 97 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.43966185 |
| 98 | inner ear receptor cell development (GO:0060119) | 2.42887006 |
| 99 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.42111465 |
| 100 | oxidative demethylation (GO:0070989) | 2.41702620 |
| 101 | T cell lineage commitment (GO:0002360) | 2.40380158 |
| 102 | synaptic vesicle maturation (GO:0016188) | 2.40015116 |
| 103 | regulation of pigment cell differentiation (GO:0050932) | 2.38915556 |
| 104 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.38659711 |
| 105 | synaptic transmission, glutamatergic (GO:0035249) | 2.38435736 |
| 106 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.38269401 |
| 107 | protein targeting to Golgi (GO:0000042) | 2.37565099 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.36880167 |
| 109 | positive regulation of protein homooligomerization (GO:0032464) | 2.36863132 |
| 110 | relaxation of cardiac muscle (GO:0055119) | 2.36850655 |
| 111 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.35817074 |
| 112 | response to host immune response (GO:0052572) | 2.35419509 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35419509 |
| 114 | synaptic vesicle endocytosis (GO:0048488) | 2.34577685 |
| 115 | neuronal action potential (GO:0019228) | 2.34079369 |
| 116 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.33399744 |
| 117 | protein targeting to vacuole (GO:0006623) | 2.33049812 |
| 118 | protein targeting to lysosome (GO:0006622) | 2.33049812 |
| 119 | establishment of protein localization to vacuole (GO:0072666) | 2.33049812 |
| 120 | behavioral response to ethanol (GO:0048149) | 2.32414406 |
| 121 | innervation (GO:0060384) | 2.31952845 |
| 122 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.31770844 |
| 123 | calcium ion import (GO:0070509) | 2.31760748 |
| 124 | chemosensory behavior (GO:0007635) | 2.31069158 |
| 125 | primary amino compound metabolic process (GO:1901160) | 2.30594940 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.30532849 |
| 127 | gene silencing by RNA (GO:0031047) | 2.30419634 |
| 128 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.30012247 |
| 129 | B cell proliferation (GO:0042100) | 2.28407935 |
| 130 | prenylation (GO:0097354) | 2.27734554 |
| 131 | protein prenylation (GO:0018342) | 2.27734554 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.27733704 |
| 133 | B cell homeostasis (GO:0001782) | 2.27660299 |
| 134 | ER overload response (GO:0006983) | 2.26993874 |
| 135 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.26960587 |
| 136 | postsynaptic membrane organization (GO:0001941) | 2.26831284 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.25791838 |
| 138 | proline transport (GO:0015824) | 2.24484705 |
| 139 | urinary tract smooth muscle contraction (GO:0014848) | 2.24201491 |
| 140 | negative regulation of osteoblast proliferation (GO:0033689) | 2.23801360 |
| 141 | negative regulation of bone resorption (GO:0045779) | 2.22534625 |
| 142 | glutamate receptor signaling pathway (GO:0007215) | 2.22272511 |
| 143 | type B pancreatic cell development (GO:0003323) | 2.21407049 |
| 144 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.20941483 |
| 145 | cellular ketone body metabolic process (GO:0046950) | 2.20697852 |
| 146 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.20642247 |
| 147 | peptide secretion (GO:0002790) | 2.17915376 |
| 148 | cAMP-mediated signaling (GO:0019933) | 2.17615598 |
| 149 | negative regulation of cell killing (GO:0031342) | 2.17347589 |
| 150 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.17347589 |
| 151 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.17179996 |
| 152 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.16263038 |
| 153 | regulation of exocytosis (GO:0017157) | 2.15211277 |
| 154 | glutamate secretion (GO:0014047) | 2.15152780 |
| 155 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.14872567 |
| 156 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.14860755 |
| 157 | protein localization to synapse (GO:0035418) | 2.14738792 |
| 158 | peptide hormone secretion (GO:0030072) | 2.14355147 |
| 159 | exploration behavior (GO:0035640) | 2.13227075 |
| 160 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.12775758 |
| 161 | regulation of neurotransmitter secretion (GO:0046928) | 2.12656726 |
| 162 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.12523747 |
| 163 | positive regulation of exocytosis (GO:0045921) | 2.12292595 |
| 164 | phosphatidylinositol phosphorylation (GO:0046854) | 2.11922775 |
| 165 | neurotransmitter secretion (GO:0007269) | 2.11891848 |
| 166 | glycosphingolipid biosynthetic process (GO:0006688) | 2.11270097 |
| 167 | cellular response to ATP (GO:0071318) | 2.11194551 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.11171731 |
| 169 | vesicle transport along microtubule (GO:0047496) | 2.10588316 |
| 170 | positive T cell selection (GO:0043368) | 2.10017972 |
| 171 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.09040539 |
| 172 | neuron-neuron synaptic transmission (GO:0007270) | 2.08682205 |
| 173 | prostate gland growth (GO:0060736) | 2.08619702 |
| 174 | regulation of germinal center formation (GO:0002634) | 2.08561601 |
| 175 | response to host (GO:0075136) | 2.08014876 |
| 176 | response to host defenses (GO:0052200) | 2.08014876 |
| 177 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.08014876 |
| 178 | negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744) | 2.07841564 |
| 179 | positive regulation of regulated secretory pathway (GO:1903307) | 2.06720687 |
| 180 | presynaptic membrane organization (GO:0097090) | 2.06663313 |
| 181 | positive regulation of membrane potential (GO:0045838) | 2.06448596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.79639549 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53696368 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.78520348 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60638433 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49014248 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.28236018 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.20662964 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20499466 |
| 9 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.16796180 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.13208373 |
| 11 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01894727 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.99493166 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99183573 |
| 14 | TP53_16413492_ChIP-PET_HCT116_Human | 1.94879326 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94071213 |
| 16 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82575040 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80078824 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76985556 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71838584 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68807593 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.67609187 |
| 22 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.65317217 |
| 23 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64878113 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63491975 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63338400 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62190437 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59673251 |
| 28 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59045446 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58577174 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57310985 |
| 31 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.55949013 |
| 32 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.55620008 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53496434 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52926135 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52825118 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52626865 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49187460 |
| 38 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.47503595 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47146618 |
| 40 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44081200 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41901266 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41121147 |
| 43 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40240000 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40162800 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38278566 |
| 46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37878363 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37866482 |
| 48 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37698333 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36741417 |
| 50 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36007529 |
| 51 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35517028 |
| 52 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34907661 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34835800 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34835800 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.34657823 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33934337 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30841244 |
| 58 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30584343 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30255375 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.30215423 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29483035 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28921860 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28675778 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28132349 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28032024 |
| 66 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.27350611 |
| 67 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27095350 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26680664 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25689507 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24670266 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24255228 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23625175 |
| 73 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23595799 |
| 74 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23326352 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22601728 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22491830 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22286399 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22277881 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20988292 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20595611 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20184587 |
| 82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19948428 |
| 83 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19706607 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19508307 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19491821 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19087067 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18754972 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18301866 |
| 89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17645756 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17356227 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17215767 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.15559315 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15285799 |
| 94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14980215 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14402513 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14357636 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13738720 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13738720 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13630244 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12845700 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12563671 |
| 102 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.12001916 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 1.11570721 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11415392 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11415392 |
| 106 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.11200667 |
| 107 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.11200667 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10103540 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09770361 |
| 110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09753075 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09138407 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08560372 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08323786 |
| 114 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08093157 |
| 115 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07904771 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07838331 |
| 117 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06815018 |
| 118 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06743932 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05450196 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04978970 |
| 121 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04608065 |
| 122 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04401600 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03678910 |
| 124 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02805389 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02669030 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02516459 |
| 127 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02281250 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02124475 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01208889 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99518214 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98960314 |
| 132 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98878277 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98597043 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97712287 |
| 135 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96998094 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95510766 |
| 137 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95169770 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94407722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.89700433 |
| 2 | MP0003183_abnormal_peptide_metabolism | 3.21820950 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 3.20179207 |
| 4 | MP0005646_abnormal_pituitary_gland | 3.04367268 |
| 5 | MP0003787_abnormal_imprinting | 2.93360713 |
| 6 | MP0002909_abnormal_adrenal_gland | 2.65658718 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.50871313 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.49470064 |
| 9 | MP0000427_abnormal_hair_cycle | 2.41723911 |
| 10 | MP0005310_abnormal_salivary_gland | 2.39039288 |
| 11 | MP0008057_abnormal_DNA_replication | 2.33004635 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.31827449 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.29707503 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.28462500 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.20776324 |
| 16 | MP0000383_abnormal_hair_follicle | 2.18598740 |
| 17 | MP0002693_abnormal_pancreas_physiology | 2.17554185 |
| 18 | MP0001188_hyperpigmentation | 2.02567711 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 1.96618727 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 1.95560695 |
| 21 | MP0001790_abnormal_immune_system | 1.87659174 |
| 22 | MP0005387_immune_system_phenotype | 1.87659174 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.85044099 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.80583459 |
| 25 | MP0001502_abnormal_circadian_rhythm | 1.77110574 |
| 26 | MP0009046_muscle_twitch | 1.76114249 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.75663399 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.74283717 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.69719461 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.68713966 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.68508418 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.65834011 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.65377385 |
| 34 | MP0001348_abnormal_lacrimal_gland | 1.60538525 |
| 35 | MP0001800_abnormal_humoral_immune | 1.59799081 |
| 36 | MP0003252_abnormal_bile_duct | 1.58933854 |
| 37 | MP0003045_fibrosis | 1.58693711 |
| 38 | MP0004130_abnormal_muscle_cell | 1.57643806 |
| 39 | MP0004510_myositis | 1.55840719 |
| 40 | MP0009745_abnormal_behavioral_response | 1.54484188 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.54401423 |
| 42 | MP0002736_abnormal_nociception_after | 1.49747285 |
| 43 | MP0004270_analgesia | 1.47436270 |
| 44 | MP0001984_abnormal_olfaction | 1.46150609 |
| 45 | MP0001486_abnormal_startle_reflex | 1.45754076 |
| 46 | MP0005671_abnormal_response_to | 1.45442109 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.41894882 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40454534 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.40223760 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.39663621 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.38459745 |
| 52 | MP0002064_seizures | 1.38156883 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.35733928 |
| 54 | MP0003880_abnormal_central_pattern | 1.35359812 |
| 55 | MP0003122_maternal_imprinting | 1.35307195 |
| 56 | MP0008872_abnormal_physiological_respon | 1.32131409 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.31660735 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.29285375 |
| 59 | MP0001944_abnormal_pancreas_morphology | 1.28412691 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.27231457 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.26623323 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.25577830 |
| 63 | MP0004742_abnormal_vestibular_system | 1.20770723 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.20553059 |
| 65 | MP0002723_abnormal_immune_serum | 1.20214730 |
| 66 | MP0002272_abnormal_nervous_system | 1.18952359 |
| 67 | MP0002254_reproductive_system_inflammat | 1.18107233 |
| 68 | MP0008569_lethality_at_weaning | 1.17688856 |
| 69 | MP0002184_abnormal_innervation | 1.16977021 |
| 70 | MP0003646_muscle_fatigue | 1.16767811 |
| 71 | MP0002168_other_aberrant_phenotype | 1.15829984 |
| 72 | MP0003091_abnormal_cell_migration | 1.12672438 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.11788709 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.11309705 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.10797603 |
| 76 | MP0003879_abnormal_hair_cell | 1.10380069 |
| 77 | MP0001819_abnormal_immune_cell | 1.10170976 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.10165398 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.10028038 |
| 80 | MP0005253_abnormal_eye_physiology | 1.09600919 |
| 81 | MP0003283_abnormal_digestive_organ | 1.08867158 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.07787824 |
| 83 | MP0002928_abnormal_bile_duct | 1.07179199 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.06413266 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.05767527 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 1.04712701 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.04671793 |
| 88 | MP0001970_abnormal_pain_threshold | 1.04186099 |
| 89 | MP0002733_abnormal_thermal_nociception | 1.02464131 |
| 90 | MP0004043_abnormal_pH_regulation | 1.02266131 |
| 91 | MP0002102_abnormal_ear_morphology | 1.00450554 |
| 92 | MP0003121_genomic_imprinting | 1.00172026 |
| 93 | MP0000470_abnormal_stomach_morphology | 1.00078626 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.95184715 |
| 95 | MP0004885_abnormal_endolymph | 0.95018438 |
| 96 | MP0003631_nervous_system_phenotype | 0.94883465 |
| 97 | MP0002163_abnormal_gland_morphology | 0.94300388 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.92810738 |
| 99 | MP0002160_abnormal_reproductive_system | 0.92482367 |
| 100 | MP0002419_abnormal_innate_immunity | 0.92114912 |
| 101 | MP0000685_abnormal_immune_system | 0.91784605 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.91223846 |
| 103 | MP0002009_preneoplasia | 0.91187561 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.90712802 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.90527196 |
| 106 | MP0000604_amyloidosis | 0.90271633 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.88752908 |
| 108 | MP0004924_abnormal_behavior | 0.88752908 |
| 109 | MP0004811_abnormal_neuron_physiology | 0.87793402 |
| 110 | MP0008877_abnormal_DNA_methylation | 0.87166435 |
| 111 | MP0003632_abnormal_nervous_system | 0.86109057 |
| 112 | MP0006292_abnormal_olfactory_placode | 0.85789827 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.84478280 |
| 114 | MP0002177_abnormal_outer_ear | 0.83947432 |
| 115 | MP0004134_abnormal_chest_morphology | 0.83707852 |
| 116 | MP0004233_abnormal_muscle_weight | 0.83244776 |
| 117 | MP0004145_abnormal_muscle_electrophysio | 0.82544895 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.81563220 |
| 119 | MP0002075_abnormal_coat/hair_pigmentati | 0.81415533 |
| 120 | MP0002398_abnormal_bone_marrow | 0.80805670 |
| 121 | MP0002006_tumorigenesis | 0.80390637 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.79106540 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.78296549 |
| 124 | MP0000716_abnormal_immune_system | 0.78261978 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.77368366 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.77243527 |
| 127 | MP0004142_abnormal_muscle_tone | 0.76668274 |
| 128 | MP0002229_neurodegeneration | 0.75259405 |
| 129 | MP0001873_stomach_inflammation | 0.75224268 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.74947158 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.74558933 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.74244142 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.73900751 |
| 134 | MP0000613_abnormal_salivary_gland | 0.73683173 |
| 135 | MP0008874_decreased_physiological_sensi | 0.73162673 |
| 136 | MP0001661_extended_life_span | 0.73134967 |
| 137 | MP0006082_CNS_inflammation | 0.72985550 |
| 138 | MP0003633_abnormal_nervous_system | 0.72557574 |
| 139 | MP0000955_abnormal_spinal_cord | 0.69884490 |
| 140 | MP0001440_abnormal_grooming_behavior | 0.69569847 |
| 141 | MP0000371_diluted_coat_color | 0.68687092 |
| 142 | MP0002882_abnormal_neuron_morphology | 0.67070446 |
| 143 | MP0003866_abnormal_defecation | 0.66575485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inability to walk (HP:0002540) | 4.29196242 |
| 2 | Febrile seizures (HP:0002373) | 4.17391282 |
| 3 | Hyperventilation (HP:0002883) | 3.90484222 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.75253764 |
| 5 | Pheochromocytoma (HP:0002666) | 3.67422570 |
| 6 | Focal motor seizures (HP:0011153) | 3.53262307 |
| 7 | Genetic anticipation (HP:0003743) | 3.26680049 |
| 8 | Clumsiness (HP:0002312) | 3.17765760 |
| 9 | Neuroendocrine neoplasm (HP:0100634) | 3.15518050 |
| 10 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.03961238 |
| 11 | Abnormality of alanine metabolism (HP:0010916) | 3.03961238 |
| 12 | Hyperalaninemia (HP:0003348) | 3.03961238 |
| 13 | Pancreatic cysts (HP:0001737) | 2.98103563 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90211453 |
| 15 | Short chin (HP:0000331) | 2.85229264 |
| 16 | Agammaglobulinemia (HP:0004432) | 2.83497814 |
| 17 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.80300896 |
| 18 | Symptomatic seizures (HP:0011145) | 2.75533753 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.75503931 |
| 20 | Type II lissencephaly (HP:0007260) | 2.72776399 |
| 21 | Dysmetric saccades (HP:0000641) | 2.67838574 |
| 22 | Epileptic encephalopathy (HP:0200134) | 2.66319472 |
| 23 | Mutism (HP:0002300) | 2.64323104 |
| 24 | Abnormal hair whorl (HP:0010721) | 2.61447016 |
| 25 | Fair hair (HP:0002286) | 2.60259038 |
| 26 | Progressive inability to walk (HP:0002505) | 2.59938111 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58230195 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58230195 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58230195 |
| 30 | Focal seizures (HP:0007359) | 2.55077055 |
| 31 | Hypoglycemic seizures (HP:0002173) | 2.53600496 |
| 32 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.49152402 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46396062 |
| 34 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.44837084 |
| 35 | Papilledema (HP:0001085) | 2.43352378 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42177010 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42177010 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.42136338 |
| 39 | Keratoconus (HP:0000563) | 2.41385605 |
| 40 | Increased corneal curvature (HP:0100692) | 2.41385605 |
| 41 | Atonic seizures (HP:0010819) | 2.38793347 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38777672 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.36492842 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34840380 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.34840380 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.34205621 |
| 47 | Visual hallucinations (HP:0002367) | 2.33306570 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.33147643 |
| 49 | Protruding tongue (HP:0010808) | 2.32490053 |
| 50 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.32134663 |
| 51 | Absence seizures (HP:0002121) | 2.30089974 |
| 52 | Prostate neoplasm (HP:0100787) | 2.29579159 |
| 53 | Acute lymphatic leukemia (HP:0006721) | 2.27168448 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.26933138 |
| 55 | Concave nail (HP:0001598) | 2.26387144 |
| 56 | Dialeptic seizures (HP:0011146) | 2.21189300 |
| 57 | Cerebellar dysplasia (HP:0007033) | 2.20897378 |
| 58 | Colitis (HP:0002583) | 2.20779164 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.20135757 |
| 60 | Generalized hypopigmentation of hair (HP:0011358) | 2.19894583 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.19706495 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.18953311 |
| 63 | Global brain atrophy (HP:0002283) | 2.16926015 |
| 64 | Osteomalacia (HP:0002749) | 2.16488769 |
| 65 | Conical tooth (HP:0000698) | 2.15152879 |
| 66 | Capillary hemangiomas (HP:0005306) | 2.14214612 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.14206690 |
| 68 | Fibular aplasia (HP:0002990) | 2.08441075 |
| 69 | Papillary thyroid carcinoma (HP:0002895) | 2.08079555 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.07551403 |
| 71 | Optic neuritis (HP:0100653) | 2.07551403 |
| 72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06828728 |
| 73 | Hypothermia (HP:0002045) | 2.06497867 |
| 74 | Diplopia (HP:0000651) | 2.05313703 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.05313703 |
| 76 | Macroglossia (HP:0000158) | 2.04765466 |
| 77 | Broad-based gait (HP:0002136) | 2.02777761 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.00294883 |
| 79 | Hyperglycemia (HP:0003074) | 1.98335468 |
| 80 | Menstrual irregularities (HP:0000858) | 1.97278624 |
| 81 | Inflammation of the large intestine (HP:0002037) | 1.96887713 |
| 82 | Partial agenesis of the corpus callosum (HP:0001338) | 1.94813547 |
| 83 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.94699139 |
| 84 | Hypoplasia of the odontoid process (HP:0003311) | 1.94034320 |
| 85 | Agitation (HP:0000713) | 1.93573726 |
| 86 | Hyperphosphatemia (HP:0002905) | 1.93546725 |
| 87 | Action tremor (HP:0002345) | 1.92930855 |
| 88 | Tubular atrophy (HP:0000092) | 1.92422009 |
| 89 | Chronic diarrhea (HP:0002028) | 1.91772411 |
| 90 | Truncal ataxia (HP:0002078) | 1.86693458 |
| 91 | Failure to thrive in infancy (HP:0001531) | 1.86167847 |
| 92 | Facial diplegia (HP:0001349) | 1.86148120 |
| 93 | Drooling (HP:0002307) | 1.84810040 |
| 94 | Excessive salivation (HP:0003781) | 1.84810040 |
| 95 | Hamartoma of the eye (HP:0010568) | 1.84510229 |
| 96 | Epileptiform EEG discharges (HP:0011182) | 1.83981158 |
| 97 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.82878288 |
| 98 | Short 1st metacarpal (HP:0010034) | 1.82878288 |
| 99 | Meningitis (HP:0001287) | 1.81612598 |
| 100 | Submucous cleft hard palate (HP:0000176) | 1.81512373 |
| 101 | Generalized tonic-clonic seizures (HP:0002069) | 1.81298875 |
| 102 | Chronic hepatic failure (HP:0100626) | 1.81211467 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80764204 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 1.80650488 |
| 105 | Recurrent viral infections (HP:0004429) | 1.79927468 |
| 106 | Impaired smooth pursuit (HP:0007772) | 1.79313356 |
| 107 | Absent speech (HP:0001344) | 1.77911618 |
| 108 | Syringomyelia (HP:0003396) | 1.77710120 |
| 109 | Spinal cord lesions (HP:0100561) | 1.77710120 |
| 110 | Neoplasm of the adrenal cortex (HP:0100641) | 1.77706750 |
| 111 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76923490 |
| 112 | Meningioma (HP:0002858) | 1.76715646 |
| 113 | Prominent nose (HP:0000448) | 1.75497748 |
| 114 | Retinal atrophy (HP:0001105) | 1.75231552 |
| 115 | Tinnitus (HP:0000360) | 1.74637820 |
| 116 | Lip pit (HP:0100267) | 1.74629354 |
| 117 | Lymphopenia (HP:0001888) | 1.74259467 |
| 118 | Spastic paraplegia (HP:0001258) | 1.73929095 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73742844 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73742844 |
| 121 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73742844 |
| 122 | Vasculitis (HP:0002633) | 1.73631016 |
| 123 | Mediastinal lymphadenopathy (HP:0100721) | 1.73459057 |
| 124 | Eczematoid dermatitis (HP:0000976) | 1.73386238 |
| 125 | Ureteral obstruction (HP:0006000) | 1.72532284 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.72291717 |
| 127 | Megalocornea (HP:0000485) | 1.71811259 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.71445969 |
| 129 | Fatigue (HP:0012378) | 1.71172195 |
| 130 | Villous atrophy (HP:0011473) | 1.71047504 |
| 131 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.71047504 |
| 132 | Gastrointestinal inflammation (HP:0004386) | 1.70680989 |
| 133 | Paraplegia (HP:0010550) | 1.70433399 |
| 134 | Flat cornea (HP:0007720) | 1.70274713 |
| 135 | Broad ribs (HP:0000885) | 1.69645987 |
| 136 | Macroorchidism (HP:0000053) | 1.69545361 |
| 137 | Hypoplasia of the fovea (HP:0007750) | 1.69030489 |
| 138 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69030489 |
| 139 | Confusion (HP:0001289) | 1.68947745 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.68518047 |
| 141 | Widely spaced teeth (HP:0000687) | 1.67642515 |
| 142 | Central scotoma (HP:0000603) | 1.67601872 |
| 143 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.67595578 |
| 144 | Hip dysplasia (HP:0001385) | 1.67443221 |
| 145 | Curly hair (HP:0002212) | 1.66436045 |
| 146 | IgA deficiency (HP:0002720) | 1.65741098 |
| 147 | Gaze-evoked nystagmus (HP:0000640) | 1.65501280 |
| 148 | Abnormality of the renal cortex (HP:0011035) | 1.65481839 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.65203273 |
| 150 | Poor eye contact (HP:0000817) | 1.64547485 |
| 151 | B lymphocytopenia (HP:0010976) | 1.64311330 |
| 152 | Asymmetry of the thorax (HP:0001555) | 1.64189389 |
| 153 | Pendular nystagmus (HP:0012043) | 1.63905443 |
| 154 | Decreased central vision (HP:0007663) | 1.63787677 |
| 155 | Abnormality of the nasal septum (HP:0000419) | 1.63678442 |
| 156 | Impaired vibratory sensation (HP:0002495) | 1.63214750 |
| 157 | J-shaped sella turcica (HP:0002680) | 1.63113674 |
| 158 | Gait imbalance (HP:0002141) | 1.62846024 |
| 159 | Deformed sella turcica (HP:0002681) | 1.62660624 |
| 160 | Disproportionate short-trunk short stature (HP:0003521) | 1.62563783 |
| 161 | Abnormality of salivation (HP:0100755) | 1.62427662 |
| 162 | Cubitus valgus (HP:0002967) | 1.61983664 |
| 163 | Ketoacidosis (HP:0001993) | 1.61268543 |
| 164 | Nephronophthisis (HP:0000090) | 1.60522919 |
| 165 | Nephrogenic diabetes insipidus (HP:0009806) | 1.60041990 |
| 166 | Ureteral stenosis (HP:0000071) | 1.60025293 |
| 167 | Inappropriate behavior (HP:0000719) | 1.59809112 |
| 168 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.59420788 |
| 169 | Hypsarrhythmia (HP:0002521) | 1.58877361 |
| 170 | Restrictive lung disease (HP:0002091) | 1.58398963 |
| 171 | Medial flaring of the eyebrow (HP:0010747) | 1.58209992 |
| 172 | Abnormality of macular pigmentation (HP:0008002) | 1.58136988 |
| 173 | Follicular hyperkeratosis (HP:0007502) | 1.58061504 |
| 174 | Chorioretinal atrophy (HP:0000533) | 1.57839804 |
| 175 | Dyschromatopsia (HP:0007641) | 1.57398291 |
| 176 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.56921866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.28076769 |
| 2 | EIF2AK3 | 3.56217970 |
| 3 | NTRK3 | 3.31986898 |
| 4 | PINK1 | 3.23635320 |
| 5 | CASK | 3.18972275 |
| 6 | TAOK3 | 2.64416199 |
| 7 | MAP4K2 | 2.60678010 |
| 8 | BLK | 2.40448885 |
| 9 | NEK9 | 2.36996017 |
| 10 | FRK | 2.34514267 |
| 11 | MAP3K14 | 2.30319904 |
| 12 | SGK2 | 2.18302350 |
| 13 | MAP2K7 | 2.11385357 |
| 14 | RIPK4 | 2.06365971 |
| 15 | BMPR2 | 2.05599453 |
| 16 | AKT3 | 1.97635226 |
| 17 | SIK3 | 1.96445119 |
| 18 | JAK1 | 1.85339970 |
| 19 | IRAK3 | 1.84410355 |
| 20 | SGK3 | 1.74899178 |
| 21 | TAF1 | 1.73638265 |
| 22 | PHKG2 | 1.69782341 |
| 23 | PHKG1 | 1.69782341 |
| 24 | MAPK15 | 1.65939723 |
| 25 | MAP3K13 | 1.64077353 |
| 26 | MAP3K4 | 1.63726517 |
| 27 | TRPM7 | 1.63101754 |
| 28 | EEF2K | 1.59303249 |
| 29 | STK3 | 1.56750105 |
| 30 | PASK | 1.54939121 |
| 31 | MAPK13 | 1.51193099 |
| 32 | IRAK4 | 1.45570739 |
| 33 | HIPK2 | 1.44104024 |
| 34 | MARK1 | 1.38008194 |
| 35 | NTRK2 | 1.36342856 |
| 36 | GRK7 | 1.32827792 |
| 37 | STK38L | 1.27683539 |
| 38 | MAP4K1 | 1.24484318 |
| 39 | PRPF4B | 1.18106096 |
| 40 | SYK | 1.16368774 |
| 41 | SGK494 | 1.14859589 |
| 42 | SGK223 | 1.14859589 |
| 43 | DAPK2 | 1.13783432 |
| 44 | CDK12 | 1.11475766 |
| 45 | NEK6 | 1.08543739 |
| 46 | CAMK1G | 1.07735479 |
| 47 | CDC42BPA | 1.07279737 |
| 48 | SCYL2 | 1.04591932 |
| 49 | LATS1 | 1.04448516 |
| 50 | PRKCH | 1.04304888 |
| 51 | FGFR3 | 1.03576490 |
| 52 | ERBB3 | 1.03507436 |
| 53 | TNK2 | 1.00720705 |
| 54 | MAPKAPK3 | 1.00273840 |
| 55 | PDGFRB | 0.99984131 |
| 56 | SIK2 | 0.99542233 |
| 57 | TXK | 0.97589868 |
| 58 | MAP3K9 | 0.95555727 |
| 59 | MELK | 0.95247368 |
| 60 | JAK3 | 0.94285871 |
| 61 | TNIK | 0.93698496 |
| 62 | CAMKK2 | 0.93450796 |
| 63 | TYK2 | 0.93391642 |
| 64 | NUAK1 | 0.92817230 |
| 65 | CAMK1D | 0.91241892 |
| 66 | WNK4 | 0.89872011 |
| 67 | CHUK | 0.89632866 |
| 68 | PAK6 | 0.88892034 |
| 69 | ZAK | 0.86760404 |
| 70 | IKBKB | 0.86086380 |
| 71 | STK24 | 0.83029760 |
| 72 | CSF1R | 0.81919240 |
| 73 | ITK | 0.81884092 |
| 74 | MAP3K2 | 0.80871605 |
| 75 | CDK3 | 0.80651720 |
| 76 | CAMKK1 | 0.77962832 |
| 77 | STK39 | 0.77806788 |
| 78 | MAPKAPK5 | 0.77260544 |
| 79 | SGK1 | 0.75650912 |
| 80 | GRK1 | 0.75611679 |
| 81 | IKBKE | 0.75537286 |
| 82 | ADRBK1 | 0.75162564 |
| 83 | TEC | 0.74834884 |
| 84 | ADRBK2 | 0.74122264 |
| 85 | BRD4 | 0.71756644 |
| 86 | MAPK11 | 0.71679396 |
| 87 | MAPK7 | 0.70617666 |
| 88 | IRAK1 | 0.68154626 |
| 89 | STK11 | 0.66108420 |
| 90 | RPS6KB1 | 0.65879374 |
| 91 | WNK1 | 0.65590917 |
| 92 | EIF2AK2 | 0.65270238 |
| 93 | PLK2 | 0.63969252 |
| 94 | EPHA3 | 0.63832602 |
| 95 | TAOK2 | 0.63591032 |
| 96 | FLT3 | 0.63047128 |
| 97 | CAMK1 | 0.62959352 |
| 98 | YES1 | 0.62635560 |
| 99 | PAK3 | 0.61807169 |
| 100 | TRIB3 | 0.60500758 |
| 101 | PRKCE | 0.60064795 |
| 102 | PRKCI | 0.59834137 |
| 103 | CSNK1A1L | 0.59458211 |
| 104 | CDK5 | 0.59163915 |
| 105 | RPS6KA2 | 0.59046536 |
| 106 | ACVR1B | 0.57854336 |
| 107 | TLK1 | 0.57180611 |
| 108 | CHEK2 | 0.56891476 |
| 109 | MINK1 | 0.56567993 |
| 110 | PRKCZ | 0.54520051 |
| 111 | PRKAA1 | 0.53676996 |
| 112 | PIK3CA | 0.53410991 |
| 113 | FES | 0.53269922 |
| 114 | HCK | 0.53039375 |
| 115 | CSNK1D | 0.52705671 |
| 116 | BTK | 0.51974717 |
| 117 | MAP3K5 | 0.51807043 |
| 118 | BMPR1B | 0.50506930 |
| 119 | LYN | 0.50269732 |
| 120 | PRKCQ | 0.49937319 |
| 121 | JAK2 | 0.49665581 |
| 122 | PTK2B | 0.48915873 |
| 123 | PDGFRA | 0.46920905 |
| 124 | GRK5 | 0.46647367 |
| 125 | PDPK1 | 0.46065512 |
| 126 | MAP2K1 | 0.45720451 |
| 127 | PRKD2 | 0.45553839 |
| 128 | OXSR1 | 0.45205726 |
| 129 | MAPK12 | 0.44847591 |
| 130 | KIT | 0.44643324 |
| 131 | RPS6KA6 | 0.44577205 |
| 132 | STK38 | 0.44330618 |
| 133 | DAPK1 | 0.44209221 |
| 134 | TGFBR2 | 0.43821135 |
| 135 | PKN1 | 0.42484172 |
| 136 | PRKCG | 0.42163156 |
| 137 | MAPK10 | 0.40795049 |
| 138 | ABL1 | 0.40355818 |
| 139 | IRAK2 | 0.38664376 |
| 140 | PIK3CG | 0.37631221 |
| 141 | PRKD3 | 0.37557175 |
| 142 | CCNB1 | 0.36664093 |
| 143 | PDK1 | 0.36232536 |
| 144 | TGFBR1 | 0.36060377 |
| 145 | CAMK2A | 0.34897982 |
| 146 | PRKCB | 0.34692736 |
| 147 | CAMK4 | 0.34113970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.66597581 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 2.22623066 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.13529143 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02294418 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.00780186 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92594162 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.85631167 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.85369719 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75470267 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69315278 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.68204990 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64441663 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.63923942 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52951421 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.47128926 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.42459431 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41350125 |
| 18 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38837818 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.38472419 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37764563 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.37060291 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36869215 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.36084112 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34761160 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30963520 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25007089 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24668184 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23968098 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22441383 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20701857 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.19783980 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18649426 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16965266 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.12784540 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.12216366 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08803983 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08236044 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06271407 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.05620945 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04161084 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03617570 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01002857 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99954518 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99615752 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99562657 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99145355 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96925517 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96469301 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.94408198 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94213805 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94106729 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.93304344 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92442026 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92347372 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92160865 |
| 56 | Melanoma_Homo sapiens_hsa05218 | 0.90972454 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90851044 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90715294 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90550921 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90313418 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87507703 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87033193 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.87030460 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86484218 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85707920 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.85352301 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84218402 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83819617 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83404366 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83189865 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83068760 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.82625831 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81369251 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81177368 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80711907 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80354041 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79266261 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78081783 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77314440 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77045027 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76915015 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.76737534 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76618137 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.76284835 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76128992 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75894097 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.75071781 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74717465 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74423257 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72699792 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72605414 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72529263 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71910137 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71839426 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71798549 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.70429817 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.70164138 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70159157 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70154812 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69337773 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68777574 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66488147 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64475823 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64080887 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62421696 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62368764 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61962648 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61941250 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61420385 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59953426 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59031743 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57041519 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56999469 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56907668 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55727872 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55207389 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54936665 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54817130 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54511958 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54173743 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53692774 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52164161 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52014994 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51984413 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50849538 |

